Document and Entity Information - USD ($) $ in Millions |
12 Months Ended | |||
---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Apr. 28, 2025 |
Jun. 30, 2024 |
|
Document and Entity Information | ||||
Document Type | 10-K/A | |||
Document Annual Report | true | |||
Document Period End Date | Dec. 31, 2024 | |||
Document Transition Report | false | |||
Entity File Number | 001-36020 | |||
Entity Registrant Name | Traws Pharma, Inc. | |||
Entity Incorporation, State or Country Code | DE | |||
Entity Tax Identification Number | 22-3627252 | |||
Entity Address, Address Line One | 12 Penns Trail | |||
Entity Address, City or Town | Newtown | |||
Entity Address, State or Province | PA | |||
Entity Address, Postal Zip Code | 18940 | |||
City Area Code | 267 | |||
Local Phone Number | 759-3680 | |||
Title of 12(b) Security | Common Stock, par value $.01 per share | |||
Trading Symbol | TRAW | |||
Security Exchange Name | NASDAQ | |||
Entity Well-known Seasoned Issuer | No | |||
Entity Voluntary Filers | No | |||
Entity Current Reporting Status | Yes | |||
Entity Interactive Data Current | Yes | |||
Entity Filer Category | Non-accelerated Filer | |||
Entity Small Business | true | |||
Entity Emerging Growth Company | false | |||
ICFR Auditor Attestation Flag | false | |||
Document Financial Statement Error Correction [Flag] | false | |||
Entity Shell Company | false | |||
Entity Public Float | $ 9.6 | |||
Entity Common Stock, Shares Outstanding | 5,334,015 | |||
Amendment Description | Traws Pharma, Inc. (the "Company") is filing this Amendment No. 1 on Form 10-K/A (this "Amendment") to its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, as filed with the Securities and Exchange Commission on March 31, 2025 (the "Original Form 10-K"), to include the information required by Part III of Form 10-K. The Part III information was previously omitted from the Original Form 10-K in reliance on General Instruction G(3) to Form 10-K, which permits the information required by Part III to be incorporated by reference from our definitive proxy statement if such statement is filed no later than 120 days after our fiscal year-end. We are filing this Amendment to provide information required in Part III of Form 10-K because a definitive proxy statement containing such information will not be filed by the Company within 120 days after the end of the fiscal year covered by the Original Form10-K. In accordance with, among other things, Rule 12b-15 under the Securities Exchange Act of 1934, as amended, this Amendment is accompanied by a currently dated certifications on Exhibits 31.3 and 31.4 by the Company's current Principal Executive Officer and Principal Financial Officer (because no financial statements have been included in this Amendment, and this Amendment does not contain or amend any disclosure with respect to Items 307 and 308 of Regulation S-K, paragraphs 3, 4 and 5 of the certification have been omitted). This Amendment is being filed to: (i) delete the reference on the cover of the Original Form 10-K to the incorporation by reference information from the Company's definitive proxy statement, (ii) amend and restate Part III, Items 10 through 14 of the Original Form 10-K in their entirety to include information previously omitted from the Original Form 10-K, and (iii) amend the Exhibit Index of the Original Form 10-K to include the filing of new certifications. Except as expressly noted above, this Amendment does not modify or update in any way the disclosures made in the Original Form 10-K and no attempt has been made in this Amendment to modify or update the other disclosures presented in the Original Form 10-K. The Amendment does not reflect events occurring after the filing of the Original Form 10-K or modify or update those disclosures that may be affected by subsequent events, other than as expressly indicated in this Amendment. Accordingly, this Amendment should be read in conjunction with the Original Form 10-K and the Company's other filings with the Securities and Exchange Commission | |||
Auditor Firm ID | 185 | 42 | ||
Auditor Name | KPMG | Ernst & Young LLP | ||
Auditor Location | Philadelphia, PA | Philadelphia, PA | ||
Entity Central Index Key | 0001130598 | |||
Current Fiscal Year End Date | --12-31 | |||
Document Fiscal Year Focus | 2024 | |||
Document Fiscal Period Focus | FY | |||
Amendment Flag | true |